147 related articles for article (PubMed ID: 478639)
1. Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines.
Buimovici-Klein E; Cooper LZ
Infect Immun; 1979 Jul; 25(1):352-6. PubMed ID: 478639
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
Vesikari T; Buimovici-Klein E
Infect Immun; 1975 Apr; 11(4):748-53. PubMed ID: 1120613
[TBL] [Abstract][Full Text] [Related]
3. HLA antigens and responses to rubella vaccination.
Harcourt GC; Best JM; Banatvala JE; Kennedy LA
J Hyg (Lond); 1979 Dec; 83(3):405-12. PubMed ID: 512353
[TBL] [Abstract][Full Text] [Related]
4. Suppression of lymphocyte PHA-responsiveness after rubella vaccination with Cendehill and RA 27/3 strains.
Vesikari T
Scand J Infect Dis; 1980; 12(1):7-11. PubMed ID: 7367839
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression and alterations of T-lymphocyte subpopulations after rubella vaccination.
Arneborn P; Biberfeld G; Wasserman J
Infect Immun; 1980 Jul; 29(1):36-41. PubMed ID: 6967455
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.
Pukhalsky AL; Shmarina GV; Bliacher MS; Fedorova IM; Toptygina AP; Fisenko JJ; Alioshkin VA
Mediators Inflamm; 2003 Aug; 12(4):203-7. PubMed ID: 14514470
[TBL] [Abstract][Full Text] [Related]
7. Failed rubella immunization in adults: association with immunologic and virological abnormalities.
Tingle AJ; Chantler JK; Kettyls GD; Larke RP; Schulzer M
J Infect Dis; 1985 Feb; 151(2):330-6. PubMed ID: 3968452
[TBL] [Abstract][Full Text] [Related]
8. Cell mediated immunity in experimental rubella infections.
Cappel R
Arch Virol; 1975; 47(4):375-9. PubMed ID: 1137503
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees.
Toyoda M; Ihara T; Nakano T; Ito M; Kamiya H
Vaccine; 1999 Apr; 17(15-16):2051-8. PubMed ID: 10217606
[TBL] [Abstract][Full Text] [Related]
10. Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.
O'Shea S; Best JM; Banatvala JE; Shepherd WM
J Infect Dis; 1985 Jan; 151(1):89-98. PubMed ID: 3965597
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte subpopulations defined by monoclonal antibodies and FC receptor binding in relation to immunosuppression in vaccine-induced rubella infection.
Arneborn P; Biberfeld G; von Stedingk LV
Acta Pathol Microbiol Immunol Scand C; 1982 Jun; 90(3):163-70. PubMed ID: 6214140
[TBL] [Abstract][Full Text] [Related]
12. Viremia in a recipient of HPV-77 Rubella virus vaccine.
Wilkins J; Salvatore MA; Leedom JM; Portnoy B
Calif Med; 1969 Mar; 110(3):224-7. PubMed ID: 5773481
[TBL] [Abstract][Full Text] [Related]
13. New Japanese rubella vaccine: comparative trials.
Best JM; Banatvala JE; Bowen JM
Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
[TBL] [Abstract][Full Text] [Related]
14. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
Wang SS; Han YR; Su WN; Chen J; Zhao K
Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
[TBL] [Abstract][Full Text] [Related]
15. Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.
Al-Nakib W; Best JM; Banatvala JE
Lancet; 1975 Jan; 1(7900):182-5. PubMed ID: 47417
[TBL] [Abstract][Full Text] [Related]
16. Study of the lymphocyte in vitro response to rubella antigen and phytohemagglutinin by a whole blood method.
Buimovici-Klein E; Vesikari T; Santangelo CF; Cooper LZ
Arch Virol; 1976; 52(4):323-31. PubMed ID: 1016065
[TBL] [Abstract][Full Text] [Related]
17. Rubella vaccination: persistence of antibodies for up to 16 years.
O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
[TBL] [Abstract][Full Text] [Related]
18. Rubella-associated arthritis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination.
Chantler JK; Ford DK; Tingle AJ
Infect Immun; 1981 Jun; 32(3):1274-80. PubMed ID: 7019092
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
[TBL] [Abstract][Full Text] [Related]
20. Persistence of rubella antibodies after vaccination: detection after experimental challenge.
Banatvala JE; Best JM; O'Shea S; Dudgeon JA
Rev Infect Dis; 1985; 7 Suppl 1():S86-90. PubMed ID: 4001741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
